Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-10-29
1982-02-16
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 422 61, 424 12, 435 7, G01N 3356, G01N 3358
Patent
active
043159079
ABSTRACT:
A heterogeneous specific binding assay method and test means for the simultaneous determination of each of a plurality of different ligands (e.g., antibodies, antigens or haptens) in a single liquid test sample. The assay may follow any conventional technique of a heterogeneous type, i.e., which includes a separation of a bound-species from a free-species form of the labeled reagent. The combined assay is accomplished by using solid-phase binding agents for the respective ligands to be determined which are differentially separable from each other, thereby permitting the use of a single label rather than a different label for each ligand to be determined. The assay is particularly suited to the simultaneous determination of different antibodies, particularly antibodies to different viral antigens, in a single serum sample.
REFERENCES:
patent: 4135884 (1979-01-01), Shen
patent: 4207307 (1980-06-01), Kaul et al.
Ben-Moyal Zohar
Fridlender Bertold
Olshevsky Udi
Tirosh Regine
Ames-Yissum
Klawitter Andrew L.
Nucker Christine M.
LandOfFree
Combined heterogeneous specific binding assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined heterogeneous specific binding assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined heterogeneous specific binding assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-942573